Exercise training for patients with multiple myeloma before stem cell transplantation
Prehabilitation Exercise Training in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
This study is looking at how an 8-week home exercise program can help people with multiple myeloma feel stronger and healthier while getting ready for a stem cell transplant, with virtual support to guide them along the way.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston University (Charles River Campus) NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10898403 on NIH RePORTER |
What this research studies
This research investigates the impact of an 8-week home-based exercise program on patients with multiple myeloma who are preparing for autologous stem cell transplantation. The program is designed to improve muscle strength and overall health outcomes through virtually supervised sessions. By focusing on enhancing physical fitness and reducing the symptom burden associated with cancer treatment, the study aims to provide a supportive intervention that can lead to better clinical outcomes for patients. Participants will be monitored for changes in physical capacity, patient-reported outcomes, and cardiometabolic health.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with multiple myeloma who are scheduled to undergo autologous stem cell transplantation.
Not a fit: Patients who are not diagnosed with multiple myeloma or those who are not eligible for autologous stem cell transplantation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved physical fitness and health outcomes for patients undergoing treatment for multiple myeloma.
How similar studies have performed: Previous research has shown that exercise interventions can improve outcomes for cancer patients, suggesting that this approach may be beneficial for multiple myeloma patients as well.
Where this research is happening
Boston, United States
- Boston University (Charles River Campus) — Boston, United States (Active)
Researchers
- Principal investigator: Normann, Amber — Boston University (Charles River Campus)
- Study coordinator: Normann, Amber
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.